おすすめの製品
由来生物
mouse
品質水準
抗体製品の状態
purified antibody
抗体製品タイプ
primary antibodies
クローン
27-156, monoclonal
分子量
calculated mol wt 101.95 kDa
observed mol wt ~120-140 kDa
精製方法
using protein G
化学種の反応性
virus
包装
antibody small pack of 100 μg
テクニック
ELISA: suitable
immunocytochemistry: suitable
immunofluorescence: suitable
immunoprecipitation (IP): suitable
neutralization: suitable
western blot: suitable
アイソタイプ
IgG2bκ
エピトープ配列
C-terminal half
タンパク質IDアクセッション番号
UniProtアクセッション番号
保管温度
-10 to -25°C
遺伝子情報
vaccinia virus ... HA(3654615)
詳細
Envelope glycoprotein B (UniProt: P13201; also known as gB) is encoded by the gB (also known as UL55) gene (Gene ID: 3077424) in human cytomegalovirus (HHV-5). Human cytomegalovirus (HCMV), a member of the β-Herpesviridae family, is a major cause of morbidity and mortality in organ transplant recipients and patients with AIDS. Its envelope glycoprotein B is reported to be essential for the infectivity and is considered to be one of the most immunogenic virus-encoded proteins. It facilitates the entry of HCMV entry into cells by binding receptors and mediating membrane fusion. Glycoprotein B is a single-pass type I membrane glycoprotein that is synthesized with a signal peptide (aa 1-22), which is subsequently cleaved off to produce the mature protein that contains a virion surface domain (aa 23-751), a transmembrane domain (aa 752-772), and an intra-virion domain (aa 773-907). The amino acid sequences 152-158 and 237-244 are critical for fusion and/or binding to host cell membrane. During virion morphogenesis, envelope glycoprotein B probably accumulates in the endosomes and trans-Golgi where secondary envelopment occurs. It is then transported to the cell surface from where it is endocytosed and is directed to the trans-Golgi network. The ectodomain of HCMV glycoprotein B forms rosette-like aggregates that are similar to rosettes formed by the EBV glycoprotein B ectodomain. Four exposed hydrophobic residues in its fusion loop are shown to be essential for rosette formation. A linear domain of glycoprotein B, designated at AD-1, represents a dominant antibody binding site on this protein and is also required for oligomerization of glycoprotein B. (Ref.: Sharma, S., et al. (2013). Virology. 435(2); 239-249; Britt, WJ., et al. (2005). J. Virol. 79(7); 4066-4079; Jean, F., et al. (2000). Proc. Natl. Acad. Sci. USA. 97(6); 2864-2869; Speckner, ., et al. (1999). J. Gen. Virol. 80(8); 2183-2191; Schoppel, K., et al. (1996). Virology. 216(1); 133-145).
特異性
Clone 27-156 is a mouse monoclonal antibody that detects the envelope glycoprotein B in Human cytomegalovirus (HCMV). It targets an epitope within the antigenic domain 1 (AD1) within the C-terminal half.
免疫原
Whole Human cytomegalovirus (HCMV).
アプリケーション
Quality Control Applications
Evaluated by Western Blotting with recombinant HCMV glycoprotein B.
Western Blotting Analysis (WB): A 1:200,000 dilution of this antibody detected recombinant HCMV glycoprotein B.
Tested applications
Immunoprecipitation Analysis: A representative lot immunoprecipitated HCMV Envelope glycoprotein B in Immunoprecipitation applications (Reschke, M., et al. (1995). J Gen Virol. 76(Pt1); 113-22; Meyer, G.A., et al. (2000). J Biol Chem. 275(6); 3857-66; Vanarsdall, A.L., et al. (2008). J Virol. 82(23);11837-50).
Immunocytochemistry Analysis: A representative lot detected HCMV Envelope glycoprotein B in Immunocytochemistry applications (Reschke, M., et al. (1995). J Gen Virol. 76(Pt1); 113-22; Jean, F., et al. (2000). Proc Natl Acad Sci USA. 97(6); :2864-9; Meyer, G.A., et al. (2000). J Biol Chem. 275(6); 3857-66; Strive, T., et al. (2002). J Virol. 76(3); 1252-64).
Neutralizing: A representative lot neutralized Envelope glycoprotein B of HCMV. (Schoppel, K., et al. (1996). Virology. 216(1);133-45; Kropff, B., et al. (1997). J Gen Virol. 78(Pt8); 1999-2007; Vanarsdall, A.L., et al. (2008). J Virol. 82(23); 11837-50).
Immunofluorescence Analysis: A representative lot detected HCMV Envelope glycoprotein B in Immunofluorescence applications (Reschke, M., et al. (1995). J Gen Virol. 76(Pt1);113-22; Jean, F., et al. (2000). Proc Natl Acad Sci USA. 97(6); 2864-9; Meyer, G.A., et al. (2000). J Biol Chem. 275(6); 3857-66; Strive, T., et al. (2002). J Virol. 76(3); 1252-64; Vanarsdall, A.L., et al. (2008). J Virol. 82(23); 11837-50).
ELISA Analysis: A representative lot detected HCMV Envelope glycoprotein B in ELISA applications (Sharma, S., et al. (2013). Virology. 435(2); 239-49).
Western Blotting Analysis: A representative lot detected HCMV Envelope glycoprotein B in Western Blotting applications (Reschke, M., et al. (1995). J Gen Virol. 76(Pt1); 113-22; Schoppel, K., et al. (1996). Virology. 216(1); 133-45; Kropff, B., et al. (1997). J Gen Virol. 78(Pt8);1999-2007; Jean, F., et al. (2000). Proc Natl Acad Sci USA. 97(6); 2864-9; Sharma, S., et al. (2013). Virology. 435(2); 239-49; Khanh Le-Trilling, V. T., et al. (2020). Cell Rep. 30(7); 2248-2260).
Note: Actual optimal working dilutions must be determined by end user as specimens, and experimental conditions may vary with the end user.
Evaluated by Western Blotting with recombinant HCMV glycoprotein B.
Western Blotting Analysis (WB): A 1:200,000 dilution of this antibody detected recombinant HCMV glycoprotein B.
Tested applications
Immunoprecipitation Analysis: A representative lot immunoprecipitated HCMV Envelope glycoprotein B in Immunoprecipitation applications (Reschke, M., et al. (1995). J Gen Virol. 76(Pt1); 113-22; Meyer, G.A., et al. (2000). J Biol Chem. 275(6); 3857-66; Vanarsdall, A.L., et al. (2008). J Virol. 82(23);11837-50).
Immunocytochemistry Analysis: A representative lot detected HCMV Envelope glycoprotein B in Immunocytochemistry applications (Reschke, M., et al. (1995). J Gen Virol. 76(Pt1); 113-22; Jean, F., et al. (2000). Proc Natl Acad Sci USA. 97(6); :2864-9; Meyer, G.A., et al. (2000). J Biol Chem. 275(6); 3857-66; Strive, T., et al. (2002). J Virol. 76(3); 1252-64).
Neutralizing: A representative lot neutralized Envelope glycoprotein B of HCMV. (Schoppel, K., et al. (1996). Virology. 216(1);133-45; Kropff, B., et al. (1997). J Gen Virol. 78(Pt8); 1999-2007; Vanarsdall, A.L., et al. (2008). J Virol. 82(23); 11837-50).
Immunofluorescence Analysis: A representative lot detected HCMV Envelope glycoprotein B in Immunofluorescence applications (Reschke, M., et al. (1995). J Gen Virol. 76(Pt1);113-22; Jean, F., et al. (2000). Proc Natl Acad Sci USA. 97(6); 2864-9; Meyer, G.A., et al. (2000). J Biol Chem. 275(6); 3857-66; Strive, T., et al. (2002). J Virol. 76(3); 1252-64; Vanarsdall, A.L., et al. (2008). J Virol. 82(23); 11837-50).
ELISA Analysis: A representative lot detected HCMV Envelope glycoprotein B in ELISA applications (Sharma, S., et al. (2013). Virology. 435(2); 239-49).
Western Blotting Analysis: A representative lot detected HCMV Envelope glycoprotein B in Western Blotting applications (Reschke, M., et al. (1995). J Gen Virol. 76(Pt1); 113-22; Schoppel, K., et al. (1996). Virology. 216(1); 133-45; Kropff, B., et al. (1997). J Gen Virol. 78(Pt8);1999-2007; Jean, F., et al. (2000). Proc Natl Acad Sci USA. 97(6); 2864-9; Sharma, S., et al. (2013). Virology. 435(2); 239-49; Khanh Le-Trilling, V. T., et al. (2020). Cell Rep. 30(7); 2248-2260).
Note: Actual optimal working dilutions must be determined by end user as specimens, and experimental conditions may vary with the end user.
物理的形状
Purified mouse monoclonal antibody IgG2b in PBS without azide.
保管および安定性
Store at -10°C to -25°C. Handling Recommendations: Upon receipt and prior to removing the cap, centrifuge the vial and gently mix the solution. Aliquot into microcentrifuge tubes and store at -20°C. Avoid repeated freeze/thaw cycles, which may damage IgG and affect product performance.
その他情報
Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.
免責事項
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
適切な製品が見つかりませんか。
製品選択ツール.をお試しください
保管分類コード
13 - Non Combustible Solids
WGK
WGK 1
引火点(°F)
Not applicable
引火点(℃)
Not applicable
適用法令
試験研究用途を考慮した関連法令を主に挙げております。化学物質以外については、一部の情報のみ提供しています。 製品を安全かつ合法的に使用することは、使用者の義務です。最新情報により修正される場合があります。WEBの反映には時間を要することがあるため、適宜SDSをご参照ください。
Jan Code
MABF3145-25UG:
MABF3145-100UG:
試験成績書（COA）
製品のロット番号・バッチ番号を入力して、試験成績書（COA） を検索できます。ロット番号・バッチ番号は、製品ラベルに「Lot」または「Batch」に続いて記載されています。
ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.
製品に関するお問い合わせはこちら（テクニカルサービス）